Fujifilm mulls doubling healthcare revenue to $10 bn by 2025
Updated:
Updated:
Share Article
AAA
Tokyo-based Fujifilm Corporation, a maker of photography devices and medical equipment, is betting high on India to grow healthcare, a space it entered over a decade ago after its traditional, photo films, business went out of the market.
The company is planning to double its revenue from healthcare business to $10 billion by 2025. In March 2020, Fujifilm as whole reported total revenue of $23 billion and health alone accounted for $5 billion.
Masaharu Morita, global marketing and new business manager, modality solutions, medical division, Fujifilm Corporation, told
The Hindu that: “We are looking at growth from multiple channels and these include organic growth through expansions and business scale-ups and also acquisitions. Growth is expected to come from Hitachi as well as the acquisition is now completed.’’
Fujifilm enters Indian diagnostics market
February 04, 2021
Launches screening centre in Bengaluru in tie-up with Dr Kutty’s Healthcare
Fujifilm Corp, the Japanese imaging and healthcare solutions company, on Thursday announced its foray into India’s fragmented diagnostics market with the launch of a health screening centre in Bengaluru in collaboration with Dr Kutty’s Healthcare (DKH).
The facility, named NURA, is equipped with artificial intelligence (AI)-enabled imaging and expert healthcare services to test for 10 common cancers including oral, breast, cervical and lung, and other lifestyle diseases, said the company.
“Cancer is very much a curable thing in Japan. In India, the survival rate is only around 30 per cent but if we can detect cancer at a ‘localised’ (early) stage then the survival rate can be more than 90 per cent,” Masaharu Morita, Global Marketing/New Business Manager, Modality Solution, Medical Division, Fujifilm, told
Fujifilm on Thursday said it plans to invest around USD 200 million (about Rs 1,450 crore) to open 100 health-screening centres in India to test 10 common cancers.
Fujifilm andDr Kutty s Healthcare on Thursday launched the first of these NURA centres , equipped with artificial intelligence (AI) enabled imaging and expert healthcare in Bengaluru, the companies said in a statement. The centre can correctly test 10 common cancers oral cancer, breast cancer, cervical cancer, lung cancer, stomach cancer, colon cancer, prostate cancer, esophageal cancer, laryngeal cancer and early signs of leukemia along with other lifestyle diseases. Masaharu Morita, global marketing and new business manager, Modality Solution, Medical Div, Fujifilm said: In the coming years, we plan to invest around USD 200 Mn to set up 100 such NURA centres across the country.